CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

CMC

41.68

-11.56%↓

FUL

54.19

-6.73%↓

USAU

9.01

-4.25%↓

Search

Ashland Global Holdings Inc

Geschlossen

BrancheRohstoffe

53.01 -8.48

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

52.92

Max

57.66

Schlüsselkennzahlen

By Trading Economics

Einkommen

-181M

-165M

Verkäufe

-117M

405M

EPS

0.28

Dividendenrendite

2.73

Gewinnspanne

-40.741

Angestellte

3,200

EBITDA

-223M

-140M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+34.54% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

2.73%

2.80%

Nächstes Ergebnis

29. Apr. 2025

Nächste Dividendenausschüttung

13. Juni 2025

Nächstes Ex-Dividendendatum

30. Mai 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

2.8B

Vorheriger Eröffnungskurs

61.49

Vorheriger Schlusskurs

53.01

Nachrichtenstimmung

By Acuity

50%

50%

95 / 170 Ranking in Basic materials

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Ashland Global Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

17. März 2025, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

Ashland Completes Sale of Avoca Business to Mane

28. Jan. 2025, 22:05 UTC

Ergebnisse

Ashland 1Q Adj EPS 28c >ASH

28. Jan. 2025, 22:04 UTC

Ergebnisse

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28. Jan. 2025, 22:04 UTC

Ergebnisse

Ashland 1Q Sales $405M >ASH

28. Jan. 2025, 22:04 UTC

Ergebnisse

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28. Jan. 2025, 22:03 UTC

Ergebnisse

Ashland 1Q Loss/Shr $3.50 >ASH

6. Nov. 2024, 22:07 UTC

Ergebnisse

Ashland 4Q EPS 39c >ASH

6. Nov. 2024, 22:07 UTC

Ergebnisse

Ashland 4Q Sales $522M >ASH

6. Nov. 2024, 22:07 UTC

Ergebnisse

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

3. Sept. 2024, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

6. Aug. 2024, 21:04 UTC

Ergebnisse

Ashland Sees FY Sales $2.1B >ASH

6. Aug. 2024, 21:03 UTC

Ergebnisse

Ashland Sees 4Q Sales $530M-$540M >ASH

6. Aug. 2024, 21:03 UTC

Ergebnisse

Ashland 3Q Adj EPS $1.49 >ASH

6. Aug. 2024, 21:02 UTC

Ergebnisse

Ashland 3Q Sales $544M >ASH

6. Aug. 2024, 21:02 UTC

Ergebnisse

Ashland 3Q Cont Ops EPS 60c >ASH

6. Aug. 2024, 21:02 UTC

Ergebnisse

Ashland 3Q EPS 12c >ASH

6. Aug. 2024, 21:02 UTC

Ergebnisse

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

7. Mai 2024, 11:01 UTC

Akquisitionen, Fusionen, Übernahmen

Ashland: Transaction Is Expected to Close in 3Q >ASH

7. Mai 2024, 10:59 UTC

Akquisitionen, Fusionen, Übernahmen

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Peer-Vergleich

Kursveränderung

Ashland Global Holdings Inc Prognose

Kursziel

By TipRanks

34.54% Vorteil

12-Monats-Prognose

Durchschnitt 77.86 USD  34.54%

Hoch 93 USD

Tief 68 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Ashland Global Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

8 ratings

5

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

56.5656 / 59.72Unterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Weak Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

95 / 170 Ranking in Rohstoffe

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.